Taiwan’s Fubon Insurance needs to navigate reinsurance credit risk despite May US$519m capital injection

Despite two capital injections worth US$1bn and a return to net profit, Fubon's credit ratings remain under scrutiny due to money owed from reinsurance counterparties.

THIS PREMIUM INSIGHT IS FOR SUBSCRIBERS ONLY.


Stay ahead with precise, independent journalism of APAC's insurance markets.

Unlocked access today:

Already subscribed? Log in here

Read next

Share this article